Insmed Inc (INSM)vsBiomotion Sciences Ordinary Shares (SLXN)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
SLXN
Biomotion Sciences Ordinary Shares
$1.34
+5.51%
HEALTHCARE · Cap: $5.20M
Smart Verdict
WallStSmart Research — data-driven comparison
SLXN leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
SLXN
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for INSM.
Margin of Safety
+99.9%
Fair Value
$2373.81
Current Price
$1.34
$2372.47 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : SLXN
The strongest argument for SLXN centers on Price/Book.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : SLXN
The primary concerns for SLXN are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while SLXN is a value play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
SLXN generates stronger free cash flow (-3M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 23/100). SLXN offers better value entry with a 99.9% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Biomotion Sciences Ordinary Shares
HEALTHCARE · BIOTECHNOLOGY · USA
Biomotion Sciences (SLXN) is an innovative biotechnology firm at the forefront of developing transformative therapies aimed at tackling severe and complex medical conditions. Specializing in regenerative medicine, the company boasts a promising pipeline of product candidates designed to enhance patient outcomes significantly. Backed by strategic collaborations that strengthen its research and development initiatives, Biomotion Sciences is positioned to capitalize on the growing demand for effective therapeutic solutions, making it a compelling investment opportunity in the dynamic biotechnology sector.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?